Privia Health Group (NASDAQ: PRVA) surged 9.86% in pre-market trading on August 7, 2025, rising to $21.73 from the prior close of $19.78.
The jump followed the release of Q2 2025 results showing a 23.4% year-over-year revenue increase to $521.15 million (below estimates), and adjusted earnings of $0.24 per share, beating expectations of $0.05.
Strong earnings outperformance is driving the stock higher despite revenue falling short of analyst forecasts.
